Business Description
![Curis Inc Curis Inc logo](https://static.gurufocus.com/logos/0C00000AU4.png?14)
Curis Inc
NAICS : 325414
SIC : 2836
ISIN : US2312692005
Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 16.38 | |||||
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -28.37 | |||||
Beneish M-Score | -3.2 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -24.8 | |||||
3-Year EBITDA Growth Rate | 5.6 | |||||
3-Year EPS without NRI Growth Rate | 9.8 | |||||
3-Year FCF Growth Rate | 12.5 | |||||
3-Year Book Growth Rate | -51.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 18.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.16 | |||||
9-Day RSI | 43.04 | |||||
14-Day RSI | 35.26 | |||||
6-1 Month Momentum % | -36.48 | |||||
12-1 Month Momentum % | -49.35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.08 | |||||
Quick Ratio | 4.08 | |||||
Cash Ratio | 3.6 | |||||
Days Sales Outstanding | 92.97 | |||||
Days Payable | 5389.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.8 | |||||
Shareholder Yield % | 2.74 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 97.61 | |||||
Operating Margin % | -501.16 | |||||
Net Margin % | -486.45 | |||||
FCF Margin % | -402.23 | |||||
ROE % | -196.36 | |||||
ROA % | -58.47 | |||||
ROIC % | -274.04 | |||||
ROC (Joel Greenblatt) % | -1166.74 | |||||
ROCE % | -64.55 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.93 | |||||
PB Ratio | 4.35 | |||||
Price-to-Tangible-Book | 86.17 | |||||
EV-to-EBIT | -0.06 | |||||
EV-to-EBITDA | -0.06 | |||||
EV-to-Revenue | 0.3 | |||||
EV-to-Forward-Revenue | 0.3 | |||||
EV-to-FCF | -0.07 | |||||
Price-to-Median-PS-Value | 0.43 | |||||
Earnings Yield (Greenblatt) % | -1666.67 | |||||
FCF Yield % | -95.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CRIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Curis Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 9.812 | ||
EPS (TTM) ($) | -8.61 | ||
Beta | 3.15 | ||
Volatility % | 230.64 | ||
14-Day RSI | 35.26 | ||
14-Day ATR ($) | 0.519248 | ||
20-Day SMA ($) | 7.10725 | ||
12-1 Month Momentum % | -49.35 | ||
52-Week Range ($) | 3.8 - 17.49 | ||
Shares Outstanding (Mil) | 5.89 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Curis Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Curis Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Curis Inc Frequently Asked Questions
What is Curis Inc(CRIS)'s stock price today?
The current price of CRIS is $6.98. The 52 week high of CRIS is $17.49 and 52 week low is $3.80.
When is next earnings date of Curis Inc(CRIS)?
The next earnings date of Curis Inc(CRIS) is 2024-08-02 Est..
Does Curis Inc(CRIS) pay dividends? If so, how much?
Curis Inc(CRIS) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |